Phase 1 Study of Autologous anti-EGFRvIII synNotch Receptor Induced anti-EphA2/IL-13Rα2 CAR (E-SYNC) T Cells in Adult Participants with EGFRvIII+ Glioblastoma

Disease Name: 
Glioblastoma, Brain Tumor
Study Status: 
Recruiting
Date: 
June 13, 2024
Detail Link ( on-site link ): 
https://alphaclinic.ucsf.edu/phase-1-study-autologous-anti-egfrviii-synnotch-rec…